11 results
10-K
2018 FY
GOSS
Gossamer Bio Inc
22 Mar 19
Annual report
4:45pm
) expanded the availability of lower pricing under the 340B drug pricing program by adding new entities to the program; (5) expanded the eligibility … and efficacy of our product candidates relative to such alternative treatments, acceptance by the medical community and patient access, drug pricing
424B4
8zzd3za rq
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
69z58
23 Jan 19
IPO registration (amended)
4:39pm
S-1
4lbumx
21 Dec 18
IPO registration
4:39pm
DRS/A
rusqv1o8ys
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
ujla7ge9
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next